Quantitative Evaluation of a Mexican and a Ghanaian Tabernaemontana Species as Alternatives to Voacanga africana for the Production of Antiaddictive Ibogan Type Alkaloids.
Felix Krengel, Jonathan Dickinson, Christopher Jenks, Ricardo Reyes-Chilpa
Chemistry & biodiversity May 1, 2020 DOI: 10.1002/cbdv.202000002 via PubMed
Summary
AI-generated from the abstractGas chromatography-mass spectrometry (GC/MS) compared the alkaloid profiles of bark and leaf from one Mexican species (Tabernaemontana arborea) and one African species (T. crassa) with the primary commercial sources of semisynthetic ibogaine, Voacanga africana root and stem bark. The qualitative and quantitative similarities between T. arborea and V. africana barks support previous reports that T. arborea is a promising alternative source of voacangine and ibogaine. The results also suggest that T. crassa could be used to produce conopharyngine and ibogaline, two compounds with the same basic skeletal structure and possibly similar antiaddictive properties as ibogaine.
Study at a glance
| Characteristics | Comparative study Qualitative Peer reviewed |
|---|---|
| Population | Tabernaemontana arborea (Mexican species) and Tabernaemontana crassa (African species) barks and leaves; Voacanga africana root and stem bark |
| Topics | Ibogaine |
| Keywords | Tabernaemontana apocynaceae Voacanga apocynaceae Ibogan type alkaloids Valuable alternative Beneficial alkaloids |
| Citations | 7 |
| Key finding | Tabernaemontana arborea bark shows qualitative and quantitative alkaloid similarity to Voacanga africana bark, supporting its potential as an alternative source of voacangine and ibogaine. |
Abstract
In continuation of our efforts to provide quantitative information on antiaddictive ibogan type alkaloid-producing Tabernaemontana species, we used gas chromatography-mass spectrometry (GC/MS) to compare the alkaloid profiles of the barks and/or leaves of one Mexican and one African species - T. arborea and T. crassa, respectively, with the primary sources of commercially available semisynthetic ibogaine, Voacanga africana root and stem bark. The qualitative and quantitative similarities between T. arborea and V. africana barks consolidate previous reports regarding the potential of the former as a promising alternative source of voacangine and ibogaine. The results also suggest that T. crassa could be used to produce conopharyngine and ibogaline, two compounds with the same basic skeletal structure and possibly similar antiaddictive properties as ibogaine.